{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:55:09Z","timestamp":1769507709807,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Mismatch repair\u2013deficient colon cancer is heterogeneous. Differentiating inherited constitutional variants from somatic genetic alterations and gene silencing is important for surveillance and genetic counseling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>This study aimed to determine the extent to which the underlying mechanism of loss of mismatch repair influences molecular and clinicopathologic features of microsatellite instability-high colon cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>This is a retrospective analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTINGS:<\/jats:title>\n            <jats:p>This study was conducted at a comprehensive cancer center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with microsatellite instability-high colon cancer of stage I, II, or III were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTION:<\/jats:title>\n            <jats:p>Patients underwent a curative surgical resection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOME MEASURES:<\/jats:title>\n            <jats:p>The main outcome measures were hypermethylation of the <jats:italic toggle=\"yes\">MLH1<\/jats:italic> promoter, biallelic inactivation, constitutional pathogenic variants, and loss of specific mismatch repair proteins.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of the 157 identified tumors with complete genetic analysis, 66% had hypermethylation of the <jats:italic toggle=\"yes\">MLH1<\/jats:italic> promoter, 18% had constitutional pathogenic variants, (Lynch syndrome), 11% had biallelic somatic mismatch repair gene pathogenic variants, and 6% had unexplained high microsatellite instability. The distribution of mismatch repair loss was as follows: MLH1 and PMS2 co-loss, 79% of the tumors; MSH2 and MSH6 co-loss, 10%; MSH6 alone, 3%; PMS2 alone, 2%; other combinations, 2%; no loss, 2%. Tumor mutational burden was lowest in MLH1- and PMS2-deficient tumors. MSH6-deficient tumors had the lowest levels of tumor-infiltrating lymphocytes, lowest MSI scores, and fewest frameshift deletions. Patients with <jats:italic toggle=\"yes\">MLH1<\/jats:italic> promoter hypermethylation were significantly more likely to be older and female and to have right-sided colon lesions than patients with biallelic inactivation. Mutation was the most prevalent second hit in tumors with biallelic inactivation and tumors of patients with Lynch syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LIMITATIONS:<\/jats:title>\n            <jats:p>This study was limited by potential selection or referral bias, missing data for some patients, and relatively small sizes of some subgroups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Clinical characteristics of mismatch repair\u2013deficient colon cancer vary with the etiology of microsatellite instability, and its molecular characteristics vary with the affected mismatch repair protein. See <jats:bold>Video Abstract<\/jats:bold> at http:\/\/links.lww.com\/DCR\/B984.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CARACTER\u00cdSTICAS DEL C\u00c1NCER DE COLON CON DEFICIENCIA EN LA REPARACI\u00d3N DE ERRORES DE EMPAREJAMIENTO EN RELACI\u00d3N CON LA P\u00c9RDIDA DE PROTE\u00cdNAS MMR, SILENCIAMIENTO DE LA HIPERMETILACI\u00d3N Y LAS VARIANTES PAT\u00d3GENAS SOM\u00c1TICAS DE GENES MMR CONSTITUCIONAL Y BIAL\u00c9LICO<\/jats:title>\n            <jats:p>\n                                 <jats:bold>ANTECEDENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>El c\u00e1ncer de colon deficiente en la reparaci\u00f3n de errores de emparejamiento es heterog\u00e9neo. La diferenciaci\u00f3n de las variantes constitucionales heredadas de las alteraciones gen\u00e9ticas som\u00e1ticas y el silenciamiento de genes es importante para la vigilancia y el asesoramiento gen\u00e9tico.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>OBJETIVO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Determinar hasta qu\u00e9 punto el mecanismo subyacente de p\u00e9rdida de reparaci\u00f3n de desajustes influye en las caracter\u00edsticas moleculares y clinicopatol\u00f3gicas del c\u00e1ncer de colon con alta inestabilidad de microsat\u00e9lites.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>DISE\u00d1O:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>An\u00e1lisis retrospectivo.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>ESCENARIO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Centro integral de c\u00e1ncer.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>PACIENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Pacientes con c\u00e1ncer de colon con inestabilidad de microsat\u00e9lites alta en estadio I, II, o III.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>INTERVENCI\u00d3N:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Resecci\u00f3n quir\u00fargica con intenci\u00f3n curativa.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>PRINCIPALES RESULTADOS Y MEDIDAS:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Hipermetilaci\u00f3n del promotor MLH1, inactivaci\u00f3n bial\u00e9lica, variante pat\u00f3gena constitucional y p\u00e9rdida de prote\u00ednas espec\u00edficas reparadoras de desajustes.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>RESULTADOS:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>De los 157 tumores identificados con un an\u00e1lisis gen\u00e9tico completo, el 66 % ten\u00eda hipermetilaci\u00f3n del promotor MLH1, el 18 % ten\u00eda una variante patog\u00e9nica constitucional (s\u00edndrome de Lynch), el 11 % ten\u00eda variantes patog\u00e9nicas som\u00e1ticas bial\u00e9licas de alg\u00fan gen MMR y el 6 % ten\u00eda una alta inestabilidad de microsat\u00e9lites sin explicaci\u00f3n. La distribuci\u00f3n de la p\u00e9rdida seg\u00fan la prote\u00edna de reparaci\u00f3n del desajuste fue la siguiente: p\u00e9rdida conjunta de MLH1 y PMS2, 79 % de los tumores; co-p\u00e9rdida de MSH2 y MSH6, 10%; MSH6 solo, 3%; PMS2 solo, 2%; otras combinaciones, 2%; sin p\u00e9rdida, 2%. La carga mutacional del tumor fue m\u00e1s baja en los tumores deficientes en MLH1 y PMS2. Los tumores con deficiencia de MSH6 ten\u00edan los niveles m\u00e1s bajos de linfocitos infiltrantes de tumores, las puntuaciones m\u00e1s bajas del sensor de IMS y la menor cantidad de deleciones por cambio de marco. Los pacientes con hipermetilaci\u00f3n del promotor MLH1 ten\u00edan significativamente m\u00e1s probabilidades de ser mayores y mujeres y de tener lesiones en el colon derecho que los pacientes con inactivaci\u00f3n bial\u00e9lica. La mutaci\u00f3n fue el segundo golpe m\u00e1s frecuente en tumores con inactivaci\u00f3n bial\u00e9lica y tumores de pacientes con s\u00edndrome de Lynch.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>LIMITACIONES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Sesgo potencial de selecci\u00f3n o referencia, datos faltantes para algunos pacientes y tama\u00f1os relativamente peque\u00f1os de algunos subgrupos.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>CONCLUSIONES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Las caracter\u00edsticas cl\u00ednicas del c\u00e1ncer de colon deficiente en reparaci\u00f3n de desajustes var\u00edan con la etiolog\u00eda de la inestabilidad de microsat\u00e9lites, y sus caracter\u00edsticas moleculares var\u00edan con la prote\u00edna de reparaci\u00f3n de desajustes afectada. Vea Resumen de video en http:\/\/links.lww.com\/DCR\/B984. <jats:italic toggle=\"yes\">(Traducci\u00f3n\u2014Dr. Felipe Bellolio<\/jats:italic>)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dcr.0000000000002452","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T18:19:31Z","timestamp":1655749171000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Characteristics of Mismatch Repair\u2013Deficient Colon Cancer in Relation to Mismatch Repair Protein Loss, Hypermethylation Silencing, and Constitutional and Biallelic Somatic Mismatch Repair Gene Pathogenic Variants"],"prefix":"10.1097","volume":"66","author":[{"given":"Ajaratu","family":"Keshinro","sequence":"first","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karuna","family":"Ganesh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Vanderbilt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Firat","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin K.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Tung","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rona","family":"Yaeger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil H.","family":"Segal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithat","family":"Gonen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinru","family":"Shia","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsofia K.","family":"Stadler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Weiser","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/ijc.33115","article-title":"Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.","volume":"147","author":"Salem","year":"2020","journal-title":"Int J Cancer"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1158\/1078-0432.CCR-19-1324","article-title":"Validation of microsatellite instability detection using a comprehensive plasma-based genotyping panel.","volume":"25","author":"Willis","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R3-20250505","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11864-015-0348-2","article-title":"Microsatellite instability testing and its role in the management of colorectal cancer.","volume":"16","author":"Kawakami","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"R4-20250505","first-page":"735","article-title":"Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.","volume":"16","author":"Battaglin","year":"2018","journal-title":"Clin Adv Hematol Oncol"},{"key":"R5-20250505","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrclinonc.2010.18","article-title":"Mismatch repair deficient colorectal cancer in the era of personalized treatment.","volume":"7","author":"Hewish","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000000695","article-title":"MLH1-deficient colorectal carcinoma with wild-type BRAF and MLH1 promoter hypermethylation harbor KRAS mutations and arise from conventional adenomas.","volume":"40","author":"Farchoukh","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jmedgenet-2011-100714","article-title":"Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.","volume":"49","author":"Parsons","year":"2012","journal-title":"J Med Genet"},{"key":"R8-20250505","first-page":"9","article-title":"The molecular characteristics of colorectal cancer: implications for diagnosis and therapy.","volume":"16","author":"Nguyen","year":"2018","journal-title":"Oncol Lett"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.humpath.2015.06.022","article-title":"Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.","volume":"46","author":"Mas-Moya","year":"2015","journal-title":"Hum Pathol"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cgh.2019.06.012","article-title":"Clinical and pathological characterization of Lynch-like syndrome.","volume":"18","author":"Pic\u00f3","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10689-012-9568-9","article-title":"Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors.","volume":"12","author":"Sourrouille","year":"2013","journal-title":"Fam Cancer"},{"key":"R12-20250505","first-page":"PO1900237","article-title":"Clinical outcomes in patients with colon cancer with microsatellite instability of sporadic or familial origin treated with adjuvant FOLFOX with or without cetuximab: a pooled analysis of the PETACC8 and N0147 trials.","volume":"4","author":"Zaanan","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/jmedgenet-2018-105698","article-title":"Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.","volume":"56","author":"Pearlman","year":"2019","journal-title":"J Med Genet"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41379-019-0289-6","article-title":"Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade.","volume":"32","author":"Wang","year":"2019","journal-title":"Mod Pathol"},{"key":"R15-20250505","first-page":"PO.17.00084","article-title":"Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data.","volume":"1","author":"Middha","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"R16-20250505","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00000478-200311000-00002","article-title":"Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.","volume":"27","author":"Shia","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R17-20250505","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.5858\/133.10.1539","article-title":"Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.","volume":"133","author":"Washington","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"R18-20250505","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10689-020-00210-4","article-title":"Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.","volume":"20","author":"Vyas","year":"2021","journal-title":"Fam Cancer"},{"key":"R19-20250505","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology.","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R20-20250505","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R21-20250505","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","article-title":"MSIsensor: microsatellite instability detection using paired tumor-normal sequence data.","volume":"30","author":"Niu","year":"2014","journal-title":"Bioinformatics"},{"key":"R22-20250505","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/PAS.0000000000000606","article-title":"Isolated loss of PMS2 immunohistochemical expression is frequently caused by heterogenous MLH1 promoter hypermethylation in Lynch syndrome screening for endometrial cancer patients.","volume":"40","author":"Kato","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R23-20250505","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.humpath.2018.04.017","article-title":"Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.","volume":"78","author":"Hemminger","year":"2018","journal-title":"Hum Pathol"},{"key":"R24-20250505","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/djy004","article-title":"The heterogeneity between Lynch-associated and sporadic MMR deficiency in colorectal cancers.","volume":"110","author":"Liu","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R25-20250505","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1200\/PO.20.00456","article-title":"Tumor-infiltrating lymphocytes, tumor mutational burden, and genetic alterations in microsatellite unstable, microsatellite stable, or mutant POLE\/POLD1 colon cancer.","volume":"5","author":"Keshinro","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"R26-20250505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/ol.2020.12302","article-title":"High frequency of microsatellite instability and its substantial co-existence with KRAS and BRAF mutations in Vietnamese patients with colorectal cancer.","volume":"21","author":"Nguyen","year":"2021","journal-title":"Oncol Lett"},{"key":"R27-20250505","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1158\/0008-5472.CAN-18-3126","article-title":"Colorectal carcinomas containing hypermethylated MLH1 promoter and wild-type BRAF\/KRAS are enriched for targetable kinase fusions.","volume":"79","author":"Cocco","year":"2019","journal-title":"Cancer Res"},{"key":"R28-20250505","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/PAS.0b013e318225c3f0","article-title":"Challenges in the identification of MSH6-associated colorectal cancer: rectal location, less typical histology, and a subset with retained mismatch repair function.","volume":"35","author":"Klarskov","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R29-20250505","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/sj.bjc.6605988","article-title":"Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats.","volume":"103","author":"You","year":"2010","journal-title":"Br J Cancer"},{"key":"R30-20250505","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-021-01581-6","article-title":"Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.","volume":"28","author":"Das","year":"2022","journal-title":"Nat Med"}],"container-title":["Diseases of the Colon &amp; Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T23:27:26Z","timestamp":1746487646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0000000000002452","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,20]]}}}